Pulmocide
London, United Kingdom· Est.
Pulmocide is developing novel inhaled medicines for serious respiratory diseases
Private Company
Total funding raised: $122M
About
Pulmocide is developing novel inhaled medicines for serious respiratory diseases
Drug DeliverySmall Molecules
Funding History
2Total raised:$122M
Series B$92M
Series A$30M